Literature DB >> 8431124

Single-dose ceftriaxone, ornidazole, and povidone-iodine enema in elective left colectomy. A randomized multicenter controlled trial. The French Association for Surgical Research.

A Fingerhut1, J M Hay.   

Abstract

Patients undergoing elective left colectomy for colonic carcinoma or diverticulosis (n = 341) were randomly assigned to three groups. Patients in groups 1 (102 patients) and 2 (122 patients) had two 5% povidone-iodine enemas whereas those in group 3 (117 patients) had saline enemas. Groups 1 and 3 received 24-hour intravenous cefotaxime sodium and metronidazole hydrochloride. Group 2 received single injections of ceftriaxone sodium (1 g) and ornidazole (1 g). Senna concentrate was administered the evening before surgery. There was no statistically significant difference found between groups 1 and 2 concerning the number of infected patients (eight vs 11), anastomotic leakages (four vs four), extra-abdominal complications (32 vs 29), or infection-related deaths (one vs zero). Despite poorer tolerance, povidone-iodine enema was more effective than saline enemas, as there were less infected patients in group 1 (8%) or groups 1 + 2 (8.5%) than in group 3 (13%). Single-dose ceftriaxone-ornidazole combined with povidone-iodine enemas is effective against infective complications in elective left colonic surgery for carcinoma or diverticular disease. Single-dose antibiotic prophylaxis reduces costs and work for the nursing staff.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431124     DOI: 10.1001/archsurg.1993.01420140105017

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  7 in total

1.  Risk factors for mortality and morbidity after elective sigmoid resection for diverticulitis: prospective multicenter multivariate analysis of 582 patients.

Authors:  Patrick Pessaux; Fabrice Muscari; Jean-François Ouellet; Simon Msika; Jean-Marie Hay; Bertrand Millat; Abe Fingerhut; Yves Flamant
Journal:  World J Surg       Date:  2003-11-26       Impact factor: 3.352

Review 2.  Cost-effective prophylaxis of surgical infections.

Authors:  S R Norrby
Journal:  Pharmacoeconomics       Date:  1996-08       Impact factor: 4.981

3.  Analysis of Ornidazole Injection in Clinical Use at Post-marketing Stage by Centralized Hospital Monitoring System.

Authors:  Ying Zhao; Zhe Chen; Pu Huang; Si-Wei Zheng; Qi-Ling Xu; Chen Shi
Journal:  Curr Med Sci       Date:  2019-10-14

4.  Protection of intestinal anastomosis with biological glues: an experimental randomized controlled trial.

Authors:  S Giuratrabocchetta; M Rinaldi; F Cuccia; M Lemma; D Piscitelli; P Polidoro; D F Altomare
Journal:  Tech Coloproctol       Date:  2011-01-25       Impact factor: 3.781

5.  A meta-analysis of randomized, controlled trials assessing the prophylactic use of ceftriaxone. A study of wound, chest, and urinary infections.

Authors:  J C Woodfield; N Beshay; A M van Rij
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

6.  Ceftriaxone versus Other Antibiotics for Surgical Prophylaxis : A Meta-Analysis.

Authors:  Silvano Esposito; Silvana Noviello; Alessandro Vanasia; Paola Venturino
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

7.  Colonic sterilization for natural orifice translumenal endoscopic surgery (NOTES) procedures: a comparison of two decontamination protocols.

Authors:  Sharon L Bachman; Emanuel Sporn; Jason L Furrer; J Andres Astudillo; Robert Calaluce; Mark A McIntosh; Brent W Miedema; Klaus Thaler
Journal:  Surg Endosc       Date:  2009-01-01       Impact factor: 4.584

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.